Colgate-Palmolive (NYSE:CL) Shares Sold by B. Riley Wealth Advisors Inc.

B. Riley Wealth Advisors Inc. reduced its position in Colgate-Palmolive (NYSE:CL) by 11.1% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 15,862 shares of the company’s stock after selling 1,989 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in Colgate-Palmolive were worth $1,631,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Blue Trust Inc. boosted its position in shares of Colgate-Palmolive by 139.6% in the 2nd quarter. Blue Trust Inc. now owns 1,270 shares of the company’s stock worth $114,000 after buying an additional 740 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its holdings in shares of Colgate-Palmolive by 0.5% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 266,664 shares of the company’s stock valued at $25,877,000 after purchasing an additional 1,303 shares in the last quarter. Continuum Advisory LLC grew its position in shares of Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after purchasing an additional 125 shares during the last quarter. Focus Financial Network Inc. increased its stake in shares of Colgate-Palmolive by 6.3% during the 2nd quarter. Focus Financial Network Inc. now owns 5,301 shares of the company’s stock worth $527,000 after purchasing an additional 314 shares in the last quarter. Finally, Atria Wealth Solutions Inc. raised its position in shares of Colgate-Palmolive by 14.8% during the 2nd quarter. Atria Wealth Solutions Inc. now owns 50,452 shares of the company’s stock worth $4,896,000 after purchasing an additional 6,494 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on CL shares. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their price target for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. TD Cowen dropped their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their target price for the company from $105.00 to $101.00 in a research note on Monday, October 28th. JPMorgan Chase & Co. raised their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $105.11.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Down 0.5 %

CL opened at $92.94 on Tuesday. Colgate-Palmolive has a 1 year low of $76.96 and a 1 year high of $109.30. The firm has a 50 day moving average price of $95.62 and a 200 day moving average price of $98.70. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The company has a market cap of $75.93 billion, a PE ratio of 26.63, a price-to-earnings-growth ratio of 3.31 and a beta of 0.43.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.15%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.